MedTrace Logo

The Intervention of Multi-vitamin With Minerals to Hyperuricemia

NCT03218709 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-07-14

No results posted yet for this study

Summary

To evaluate the validity of multi-vitamin-and-minerals intervention on uric acid metabolism in hyperuricemic adults.

Conditions

  • Hyperuricemia

Interventions

COMBINATION_PRODUCT

High-dose multi-vitamins with minerals

The high-dose multi-vitamins with minerals contained vitaminB1 0.72mg,vitamin B20.72mg,vitamin B12 1.35μg,folic acid 0.37mg,vitamin C 0.27mg,vitamin D 5.04μg,selenium 30.5μg per pill, respectively.

COMBINATION_PRODUCT

Low-dose multi-vitamins with minerals

The low-dose multi-vitamins with minerals contained vitaminB1 0.72mg,vitamin B20.72mg,vitamin B12 1.35μg,folic acid 0.20mg,vitamin C 0.50mg,vitamin D 5.04μg,selenium 30.5μg per pill, respectively.

COMBINATION_PRODUCT

Hypouricemic tablets

The hypouricemic tablets contained skipjack,salvia and rosemary extract.

COMBINATION_PRODUCT

Placebo

The placebo tablets contained maltodextrin and tartrazine.

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Min Xia, Ph.D · Department of Nutrition,School of Public Health,Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-01-31
Completion
2018-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03218709 on ClinicalTrials.gov